EQT's Springer Science to announce IPO plans

Springer Science shareholders EQT and GIC are understood to be following a dual-track process, which could see the business either float or go to another private equity owner in an SBO. Earlier this year, EQT was believed to be in talks with fellow GPs Carlyle, Providence, KKR and BC Partners over the sale of the asset, which is expected to fetch €3-4bn.

Should EQT and GIC favour the IPO route, Springer Science could list as early as July, Reuters reported.

EQT acquired Springer Science from Candover and Cinven in 2009 in a buyout valued at €2.3bn. The deal also saw Singaporean sovereign wealth fund GIC invest for a minority stake. A €1bn debt package was arranged and underwritten by Goldman Sachs International, Unicredit, Barclays Capital and Deutsche Bank.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Exits
• Media
• Germany
• EQT
• IPO